Convergent genetic adaptation in human tumors developed under systemic hypoxia and in populations living at high altitudes
Carlota Arenillas,Jose Ruiz-Cantador,Lucia Celada,Bruna Calsina,Eduardo Garcia-Galea,Debayan Datta,Roberta Fasani,Ana Belen Moreno-Cardenas,Juan Jose Alba-Linares,Berta Miranda,Angel M. Martinez-Montes,Cristina Alvarez Escola,Beatriz Lecumberri,Elvira Ana Gonzalez Garcia,Shahida K. Flores,Emmanuel Esquivel,Yanli Ding,Rita Maria Regojo Zapata,Jose Juan Pozo-Kreilinger,Carmela Iglesias,Trisha Dwight,Christopher Muir,Amelia Oleaga Alday,M Elvira Garrido-Lestache Rodriguez-Monte,M Jesus Del Cerro,Isaac Martinez-Bendayan,Delmar M Lourenco Jr.,Maria Adelaide A Pereira,Nelly Burnichon,Alexandre Buffet,Craig Broberg,Paxton Dickson,Mario Fernandez Fraga,Jose Luis Llorente Pendas,Joaquin Rueda Soriano,Francisco Buendia Fuentes,Sergio P A Toledo,Roderick Clifton-Bligh,Rodrigo Dienstmann,Jaume Capdevila,Anne-Paule Gimenez-Roqueplo,Judith Favier,Donate Weghorn,Paolo Nuciforo,William Young Jr.,Alexander R Opotowsky,Anand Vaidya,Irina Bancos,Mercedes Robledo,Anna Casteras,Laura Dos-Subira,Maria Dolores Chiara,Igor Adameyko,Patricia L.M. Dahia,Rodrigo A. Toledo
DOI: https://doi.org/10.1101/2024.06.10.594693
2024-06-12
Abstract:EPAS1HIF2a is the primary gene implicated in systemic hypoxia adaptation. Conversely, aberrantly activated EPAS1HIF2a acts as a tumor driver against which anti-tumor therapeutics are proven effective. We elucidated connections between adaptation to systemic hypoxia in high-altitude populations, such as Tibetans and Sherpas, and human tumors. Similar to the accelerated adaptability observed in high-altitude populations via genetic introgression, tumors from patients with hypoxia since birth exhibited impaired DNA repair and increased mutation burden. As in high-altitude dwellers, EPAS1HIF2a genetic variants were positively selected within sympathetic tumors developed under hypoxia, with a consistently high frequency of 90%. Bulk and single-cell RNA sequencing followed by in vitro studies have shown that hypoxia and EPAS1HIF2a gain-of-function tumor mutations induce COX4i2 expression and impair mitochondrial respiration, indicating that decreased cellular oxygen consumption may confer a proliferative advantage in hypoxia. Analyzing medical data from a patient cohort with hypoxia since birth who developed/did not develop tumors revealed tissue-specific and time-dependent tumorigenic effects of systemic hypoxia, which is limited to oxygen-sensitive and responsive cells, particularly during the postnatal period. This study supports connections between the EPAS1HIF2a genetic adaptation in human tumors developed under systemic hypoxia to populations living in high altitudes. The genetic adaptations in populations to different stressors can be explored further to understand tumorigenesis and tumor evolution.
Cancer Biology